Cargando…
Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory Activity
Aberrant activation of the NLRP3 inflammasome promotes the pathogenesis of many inflammatory diseases. The development of the NLRP3 inflammasome inhibitors from existing drugs for new therapeutic purposes is becoming more important. Candesartan is an angiotensin II receptor antagonist widely used as...
Autores principales: | Lin, Wen-Yu, Li, Lan-Hui, Hsiao, Ya-Yun, Wong, Wei-Ting, Chiu, Hsiao-Wen, Hsu, Hsien-Ta, Peng, Yi-Jen, Ho, Chen-Lung, Chernikov, Oleg V., Cheng, Shu-Meng, Yang, Shih-Ping, Hua, Kuo-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163344/ https://www.ncbi.nlm.nih.gov/pubmed/35669789 http://dx.doi.org/10.3389/fimmu.2022.870627 |
Ejemplares similares
-
The leaves of the seasoning plant Litsea cubeba inhibit the NLRP3 inflammasome and ameliorate dextran sulfate sodium-induced colitis in mice
por: Wong, Wei-Ting, et al.
Publicado: (2022) -
Mechanistic Insight Into the Activation of the NLRP3 Inflammasome by Neisseria gonorrhoeae in Macrophages
por: Li, Lan-Hui, et al.
Publicado: (2019) -
Critical Role for the NLRP3 Inflammasome in Mediating IL-1β Production in Shigella sonnei-Infected Macrophages
por: Li, Lan-Hui, et al.
Publicado: (2020) -
Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
por: Wong, Wei-Ting, et al.
Publicado: (2018) -
Editorial: NLRP3 Inflammasome: Regulatory Mechanisms, Role in Health and Disease and Therapeutic Potential
por: Chernikov, Oleg V., et al.
Publicado: (2021)